ALGID Fundamental Analysis - EGIDE

Fundamental Rating

Taking everything into account, ALGID scores 2 out of 10 in our fundamental rating. ALGID was compared to 50 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of ALGID have multiple concerns. ALGID has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALGID has reported negative net income.

In the past year ALGID has reported a negative cash flow from operations.

The reported net income has been mixed in the past 5 years: ALGID reported negative net income in multiple years.

In multiple years ALGID reported negative operating cash flow during the last 5 years.

1.2 Ratios

ALGID has a worse Return On Assets (-9.81%) than 84.00% of its industry peers.

The Return On Equity of ALGID (-35.91%) is worse than 80.00% of its industry peers.

		Industry Rank	Sector Rank
ROA	-9.81%
ROE	-35.91%
ROIC	N/A

ROA(3y)-13.63%

ROA(5y)-7.33%

ROE(3y)-55.38%

ROE(5y)-31.02%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of ALGID (65.40%) is better than 86.00% of its industry peers.

In the last couple of years the Gross Margin of ALGID has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for ALGID so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	65.4%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.15%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALGID does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ALGID has more shares outstanding

ALGID has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.77, we must say that ALGID is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.77, ALGID is doing worse than 70.00% of the companies in the same industry.

A Debt/Equity ratio of 0.82 indicates that ALGID is somewhat dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.82, ALGID is doing worse than 78.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.82
Debt/FCF	N/A
Altman-Z	1.77

ROIC/WACCN/A

WACC7.08%

2.3 Liquidity

A Current Ratio of 1.61 indicates that ALGID should not have too much problems paying its short term obligations.

ALGID has a Current ratio of 1.61. This is comparable to the rest of the industry: ALGID outperforms 52.00% of its industry peers.

A Quick Ratio of 0.80 indicates that ALGID may have some problems paying its short term obligations.

The Quick ratio of ALGID (0.80) is worse than 78.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.61
Quick Ratio	0.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALGID shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.96%, which is quite impressive.

The Revenue for ALGID has decreased by -18.27% in the past year. This is quite bad

Measured over the past years, ALGID shows a very strong growth in Revenue. The Revenue has been growing by 28.35% on average per year.

EPS 1Y (TTM)28.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%56.65%

Revenue 1Y (TTM)-18.27%

Revenue growth 3Y28.35%

Revenue growth 5YN/A

Sales Q2Q%-16.84%

3.2 Future

ALGID is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -25.99% yearly.

ALGID is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.68% yearly.

EPS Next Y-41.48%

EPS Next 2Y-51.41%

EPS Next 3Y-25.99%

EPS Next 5YN/A

Revenue Next Year22.46%

Revenue Next 2Y-1.63%

Revenue Next 3Y0.68%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALGID. In the last year negative earnings were reported.

ALGID is valuated quite expensively with a Price/Forward Earnings ratio of 28.26.

ALGID's Price/Forward Earnings ratio is in line with the industry average.

ALGID's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.46.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	28.26

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as ALGID's earnings are expected to decrease with -25.99% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-51.41%

EPS Next 3Y-25.99%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALGID!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

EGIDE

EPA:ALGID (12/24/2025, 7:00:00 PM)

1.17

-0.26 (-18.18%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryElectronic Equipment, Instruments & Components

Earnings (Last)10-20 2025-10-20

Earnings (Next)04-27 2026-04-27

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap22.94M

Revenue(TTM)30.01M

Net Income(TTM)-2.38M

Analysts86.67

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	28.26
P/S	0.76
P/FCF	N/A
P/OCF	N/A
P/B	3.47
P/tB	3.47
EV/EBITDA	N/A

EPS(TTM)-0.13

EYN/A

EPS(NY)0.04

Fwd EY3.54%

FCF(TTM)-0.09

FCFYN/A

OCF(TTM)-0.08

OCFYN/A

SpS1.53

BVpS0.34

TBVpS0.34

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-9.81%
ROE	-35.91%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	65.4%
FCFM	N/A

ROA(3y)-13.63%

ROA(5y)-7.33%

ROE(3y)-55.38%

ROE(5y)-31.02%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.15%

GM growth 5YN/A

F-Score4

Asset Turnover1.24

Health

		Industry Rank	Sector Rank
Debt/Equity	0.82
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	20.64%
Cap/Sales	0.96%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.61
Quick Ratio	0.8
Altman-Z	1.77

F-Score4

WACC7.08%

ROIC/WACCN/A

Cap/Depr(3y)34.7%

Cap/Depr(5y)225.04%

Cap/Sales(3y)2%

Cap/Sales(5y)3.91%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)28.96%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%56.65%

EPS Next Y-41.48%

EPS Next 2Y-51.41%

EPS Next 3Y-25.99%

EPS Next 5YN/A

Revenue 1Y (TTM)-18.27%

Revenue growth 3Y28.35%

Revenue growth 5YN/A

Sales Q2Q%-16.84%

Revenue Next Year22.46%

Revenue Next 2Y-1.63%

Revenue Next 3Y0.68%

Revenue Next 5YN/A

EBIT growth 1Y26.54%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-6276.67%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-462.88%

OCF growth 3YN/A

OCF growth 5YN/A

EGIDE / ALGID.PA FAQ

Can you provide the ChartMill fundamental rating for EGIDE?

ChartMill assigns a fundamental rating of 2 / 10 to ALGID.PA.

What is the valuation status for ALGID stock?

ChartMill assigns a valuation rating of 0 / 10 to EGIDE (ALGID.PA). This can be considered as Overvalued.

Can you provide the profitability details for EGIDE?

EGIDE (ALGID.PA) has a profitability rating of 2 / 10.

EGIDE (ALGID.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

EGIDE / ALGID.PA FAQ

Can you provide the ChartMill fundamental rating for EGIDE?

What is the valuation status for ALGID stock?

Can you provide the profitability details for EGIDE?